AI-powered drug company spun out of Google’s DeepMind says human trials are ‘very close’ After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials.

Demis Hassabis, chief of Google DeepMind, believes there's a 50% chance of achieving AGI within 5 years. AGI means ...

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

The UK-based firm, which emerged from Google DeepMind in 2021, has not disclosed the target condition or a specific timeline for the trial’s commencement.

AI that is as powerful as the human brain could arrive within the next few years, according to the boss of Google-owned AI lab DeepMind. The Wall Street Journal reported the news .

Google has announced the consolidation of its formerly separate AI research labs — Google Brain and DeepMind — into a new unit named Google DeepMind. The new team will spearhead groundbreaking ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes ...

An artificial intelligence system built by Google DeepMind, the tech giant’s primary artificial intelligence lab, has ...

Google's DeepMind AI Solves Problems Like a Human Published Mar 15, 2017 at 12:46 PM EDT Updated Mar 20, 2017 at 1:16 PM EDT ...

As DeepMind explains, they trained their AI agents to behave the way some economists model human decision making. That is, selfish and always rational. "The research may enable us to better ...